Status:
COMPLETED
A Representational Intervention to Promote Preparation for End-of-life Decision Making
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Nursing Research (NINR)
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed randomized controlled trial will test the SPIRIT (Sharing the Patient's Illness Representations to Increase Trust) intervention designed to improve discussions about end-of-life care betw...
Detailed Description
Dialysis is central to survival for 450,000 Americans with end-stage renal disease (ESRD). Yet patients on dialysis have significant comorbidities and high mortality rates (24% annually). One out of f...
Eligibility Criteria
Inclusion
- for patients,
- self-identified Caucasian or African American;
- receiving either center-hemodialysis or home-peritoneal dialysis for at least 6 months prior to enrollment;
- availability of an individual chosen by the patient who can be present during the intervention as a surrogate decision maker;
- age 18 years or older;
- ability to participate in health care decisions as evidenced by less than 3 errors on the Short Portable Mental Status Questionnaire (SPMSQ), suggesting normal mental functioning;
- ability to read, write, and speak English.
- a CCI score of ≥6;
- hospitalization in the last 6 months, a CCI score of 5, including congestive heart failure (CHF).
- for surrogates,
- age 18 years or older (to serve as a surrogate decision maker, the individual must be an adult);
- willingness to serve as the surrogate decision maker and participate in the intervention with the patient;
- ability to read, write, and speak English.
Exclusion
- Patients who are too sick to participate in an hour-long interview, who require special care and assistance, who would not be able to care for their needs will be excluded.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01259011
Start Date
March 1 2010
End Date
April 1 2014
Last Update
September 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States, 27599